InsiderTrades

Form 4 for DGX Quest Diagnostics

Accepted 2022-11-02 00:00:00 ET · period of report 2022-11-01 · accession 0001022079-22-000152 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2022-11-02 2022-11-01 DGX RING TIMOTHY M Dir M - OptEx $61.07 +2,000 25.9K +8% +$122.1K
D 2022-11-02 2022-11-01 DGX RING TIMOTHY M Dir S - Sale+OE $144.06 -2,000 24.1K -8% -$288.1K
DM 2022-11-02 2022-11-01 DGX RING TIMOTHY M Dir M - OptEx $61.07 -2,000 0 -100% -$122.1K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-11-01 M A 260 $61.23 24,193 D — —
2 Common Common Stock 2022-11-01 S D 2,000 $144.06 24,149 D — — (F1) The amount includes approximately 216 shares acquired via dividend reinvestment pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
3 Common Common Stock 2022-11-01 M A 1,371 $60.79 25,564 D — —
4 Common Common Stock 2022-11-01 M A 369 $62.01 25,933 D — —
5 Derivative Stock Options (Right to Buy) 2022-11-01 M D 369 $62.01 972 D $62.01 · 2013-10-01 to 2023-10-01 369 Common Stock
6 Derivative Stock Options (Right to Buy) 2022-11-01 M D 260 $61.23 0 D $61.23 · — to 2023-05-21 260 Common Stock (F2) Options vested in three equal annual installments beginning on the first annual anniversary of the grant date.
7 Derivative Stock Options (Right to Buy) 2022-11-01 M D 1,371 $60.79 0 D $60.79 · 2013-07-01 to 2023-07-01 1,371 Common Stock